Sino Biological,Inc. Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Market Capitalization	8,980	8,223	7,523	10,646	12,876	23,508
Market Cap Growth	20.83%	9.30%	-29.33%	-17.32%	-45.23%	-
Enterprise Value	5,772	5,013	3,684	5,947	6,915	17,218
Last Close Price	73.83	67.60	57.79	74.97	88.81	157.68
PE Ratio	57.11	55.66	61.70	40.93	42.50	32.65
Forward PE	50.92	52.81	42.22	34.41	38.78	20.76
PS Ratio	12.34	11.75	12.26	16.47	22.41	24.35
PB Ratio	1.68	1.55	1.30	1.67	2.02	3.48
P/TBV Ratio	1.79	1.65	1.38	1.67	2.02	3.48
P/FCF Ratio	146.32	182.15	171.82	-	137.95	39.53
P/OCF Ratio	50.79	56.25	66.15	33.01	51.63	36.58
EV/Sales Ratio	7.93	7.17	6.00	9.20	12.04	17.84
EV/EBITDA Ratio	28.40	32.27	38.90	32.67	31.25	24.29
EV/EBIT Ratio	51.38	55.57	125.79	43.80	33.98	24.72
EV/FCF Ratio	94.04	111.05	84.15	-	74.09	28.95
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.23	0.30	0.56	0.42	0.29	0.07
Debt / FCF Ratio	0.76	1.19	1.54	-	0.76	0.08
Net Debt / Equity Ratio	-0.60	-0.60	-0.67	-0.75	-0.90	-0.96
Net Debt / EBITDA Ratio	-18.09	-20.40	-40.98	-26.17	-25.90	-9.12
Net Debt / FCF Ratio	-52.28	-70.19	-88.66	6.61	-61.41	-10.87
Asset Turnover	0.13	0.12	0.10	0.10	0.09	0.23
Inventory Turnover	2.72	2.65	2.92	2.52	2.63	3.54
Quick Ratio	25.86	22.41	20.86	36.64	47.60	67.82
Current Ratio	26.66	23.03	21.30	37.17	48.12	68.30
Return on Equity (ROE)	2.83%	2.67%	2.01%	4.08%	4.62%	17.89%
Return on Assets (ROA)	1.21%	0.97%	0.29%	1.29%	1.89%	10.42%
Return on Invested Capital (ROIC)	4.12%	3.68%	1.45%	10.95%	38.86%	234.42%
Return on Capital Employed (ROCE)	2.10%	1.70%	0.50%	2.10%	3.20%	10.30%
Earnings Yield	1.75%	1.80%	1.62%	2.44%	2.35%	3.06%
FCF Yield	0.68%	0.55%	0.58%	-6.77%	0.73%	2.53%
Dividend Yield	7.04%	7.69%	1.73%	2.67%	2.25%	3.34%
Payout Ratio	386.77%	411.67%	209.57%	99.33%	224.45%	-
Buyback Yield / Dilution	3.51%	4.93%	0.97%	-13.44%	-5.79%	-11.11%
Total Shareholder Return	10.71%	12.62%	2.71%	-10.77%	-3.54%	-7.77%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.